Log in

Taro Pharmaceutical Industries SEC Filings & 10K Form (NYSE:TARO)

$87.27
+11.05 (+14.50 %)
(As of 11/15/2019 04:00 PM ET)
Today's Range
$81.00
Now: $87.27
$88.60
50-Day Range
$73.89
MA: $77.12
$88.15
52-Week Range
$72.97
Now: $87.27
$109.42
Volume296,888 shs
Average Volume45,008 shs
Market Capitalization$3.36 billion
P/E Ratio12.07
Dividend YieldN/A
Beta0.43

SEC Filings

Taro Pharmaceutical Industries (NYSE:TARO) SEC Filings

DateFilerForm TypeView
11/15/2019
3:35 PM
Taro Pharmaceutical Industries (Subject)
Form SC TO-I
11/15/2019
9:09 AM
Taro Pharmaceutical Industries (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/04/2019
4:09 PM
Taro Pharmaceutical Industries (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/08/2019
4:02 PM
Taro Pharmaceutical Industries (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/21/2019
8:29 AM
Taro Pharmaceutical Industries (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/20/2019
3:41 PM
Taro Pharmaceutical Industries (Filer)
Form 20-F
Registration statement / Annual report / Transition report  
05/16/2019
12:32 PM
Taro Pharmaceutical Industries (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/31/2019
1:15 PM
Taro Pharmaceutical Industries (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/15/2019
4:09 PM
Taro Pharmaceutical Industries (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/31/2018
7:41 AM
Taro Pharmaceutical Industries (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/07/2018
4:18 PM
Taro Pharmaceutical Industries (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/05/2018
4:20 PM
Taro Pharmaceutical Industries (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/29/2018
2:28 PM
Taro Pharmaceutical Industries (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/28/2018
4:20 PM
Taro Pharmaceutical Industries (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/02/2018
1:01 PM
Taro Pharmaceutical Industries (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/22/2018
10:29 AM
Taro Pharmaceutical Industries (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/21/2018
3:24 PM
Taro Pharmaceutical Industries (Filer)
Form 20-F
Registration statement / Annual report / Transition report  
05/11/2018
2:30 PM
Taro Pharmaceutical Industries (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/31/2018
4:23 PM
Taro Pharmaceutical Industries (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/03/2018
3:21 PM
Taro Pharmaceutical Industries (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
This page was last updated on 11/16/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel